Six Scientists from First WHO Wuhan Mission Named to New WHO Virus Origins Investigative Group 13/10/2021 Kerry Cullinan The World Health Organization (WHO) has named 26 scientists to a new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which will take forward the work of the international expert group that led an initial mission to Wuhan in January 2021, as well as investigating future pandemics. Six of the scientists are associated […] Continue reading -> India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Brazil’s High COVID-19 Death Toll is Blamed on Government’s ‘Deliberate’ Spread of Virus 11/10/2021 Kerry Cullinan Brazil’s official death toll from COVID-19 reached 600,000 late Friday, the second-highest in the world after the US – and a leading epidemiologist blames the Bolsonaro administration for deliberately spreading the virus to achieve “herd immunity”. “Brazil’s federal government put in place a deliberate policy of exposing the population to the pandemic,” according to Cesar […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India Approves COVID-19 Vaccine Covaxin for Children From the Age of Two 12/10/2021 Kerry Cullinan The Indian government’s Subject Expert Committee (SEC) has recommended the use of the country’s home-grown COVID-19 vaccine, Covaxin, for children from the age of two. This is the first vaccine in the world to be approved for such young children. Pfizer’s vaccine was recently approved for children from the age of 12 in the US. […] Continue reading -> WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Brazil’s High COVID-19 Death Toll is Blamed on Government’s ‘Deliberate’ Spread of Virus 11/10/2021 Kerry Cullinan Brazil’s official death toll from COVID-19 reached 600,000 late Friday, the second-highest in the world after the US – and a leading epidemiologist blames the Bolsonaro administration for deliberately spreading the virus to achieve “herd immunity”. “Brazil’s federal government put in place a deliberate policy of exposing the population to the pandemic,” according to Cesar […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Experts Recommend Third Booster to Supplement Chinese Vaccines 11/10/2021 Kerry Cullinan The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) has recommended that people over the age of 60 who received the Chinese Sinovac and Sinopharm vaccines, should get a third shot – possibly with another vaccine. “The use of a heterologous platforms vaccine for the additional dose may also be considered based on […] Continue reading -> Brazil’s High COVID-19 Death Toll is Blamed on Government’s ‘Deliberate’ Spread of Virus 11/10/2021 Kerry Cullinan Brazil’s official death toll from COVID-19 reached 600,000 late Friday, the second-highest in the world after the US – and a leading epidemiologist blames the Bolsonaro administration for deliberately spreading the virus to achieve “herd immunity”. “Brazil’s federal government put in place a deliberate policy of exposing the population to the pandemic,” according to Cesar […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Brazil’s High COVID-19 Death Toll is Blamed on Government’s ‘Deliberate’ Spread of Virus 11/10/2021 Kerry Cullinan Brazil’s official death toll from COVID-19 reached 600,000 late Friday, the second-highest in the world after the US – and a leading epidemiologist blames the Bolsonaro administration for deliberately spreading the virus to achieve “herd immunity”. “Brazil’s federal government put in place a deliberate policy of exposing the population to the pandemic,” according to Cesar […] Continue reading -> WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Believes 70% Vaccination Target is Possible – But Only if Wealthy Countries Make Way for COVAX and Africa 07/10/2021 Kerry Cullinan The World Health Organization (WHO) believes that is possible to get 70% of the world vaccinated against COVID-19 by June – but only if wealthy countries redirect their doses and orders to poorer countries that are lagging behind. Eleven billion vaccines are needed to reach the 70% target, said WHO Director-General Dr Tedros Adhanom Ghebreyesus […] Continue reading -> Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Moderna is Urged to Work Through African Partnership to Set up mRNA Facility 07/10/2021 Kerry Cullinan Moderna should work through the Partnership for African Vaccine Manufacturing (PAVM) if it wants to invest in vaccine production on the continent, according to the head of the Africa Centers for Disease Control (CDC). The company announced on Thursday that it plans to invest $500-million in a “state-of-the-art mRNA facility” in Africa that can produce […] Continue reading -> WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Approves First Ever Malaria Vaccine 06/10/2021 Kerry Cullinan The World Health Organization (WHO) has given the go-ahead for children to get the first-ever malaria vaccine in areas where there is a high to moderate risk of infection. The vaccine, known as RTS,S, is the first to have been approved against a parasitic disease. It has been tested on 800,000 children in Ghana, Kenya […] Continue reading -> African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
African Medicines Agency Will Come into Being on 5 November – after 15th African Country Ratifies & Deposits AMA Treaty 06/10/2021 Kerry Cullinan Africans are a step closer to speedier access to newer, safer medicines following this week’s notification by 15 African Union (AU) member countries that they have formally ratified and deposited their accord to create a new African Medicines Agency (AMA). Although the AU adopted the treaty to set up the AMA back in February 2019, […] Continue reading -> African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
African Countries are the Focus of New Maternal Mortality Targets 05/10/2021 Kerry Cullinan Nineteen countries have been prioritised for support to implement new global targets aimed at preventing maternal and newborn deaths. This emerged at the launch on Tuesday of the new targets, which were developed by the World Health Organization (WHO), UN Population Fund (UNFPA) and their partners in the Ending Preventable Maternal Mortality (EPMM) initiative. UNFPA […] Continue reading -> Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Indian Generic Companies Are Ready to Make Merck’s COVID-19 Antiviral Pill 04/10/2021 Kerry Cullinan Indian generic drug manufacturers are poised to make the antiviral pill, molnupiravir, which halved hospitalisations in a trial of high-risk people with COVID-19. Merck, which developed molnupiravir in collaboration with Ridgeback Biotherapeutics, has awarded non-exclusive, voluntary licensing agreements to eight generic companies in India since April in anticipation of positive trial results. According to Merck, […] Continue reading -> Posts navigation Older postsNewer posts